Upcoming Medical Conferences in Bergamo

European Association for Cancer Research (EACR)-European Society for Medical Oncology (ESMO) Joint Conference on Liquid Biopsies is organized by European Association for Cancer Research (EACR) and will be held from May 15 - 17, 2019 at Giovanni XXIII Congress Center, Bergamo, Lombardia, Italy. Target Audience: Translational scientists, biologists, geneticists, clinical chemists, molecular pathologists, oncologists, patient advocates, primary care (GPs), radiologists, clinical and non-clinical trainees, biotech and diagnostic companies, Pharma, bioengineers. Conference Description: This EACR-ESMO Joint Conference will provide a comprehensive overview of liquid biopsies in cancer. It will cover what is already in clinical practice, what is on the horizon for liquid biopsies in cancer patient management and the latest new techniques. This meeting aims to develop our understanding of the potential of liquid biopsies. This includes to support early detection of cancer; as prognostic, pharmacodynamic and predictive biomarkers of treatment efficacy and resistance; and for patient monitoring, including of minimal residual disease for early identification of disease relapse. It will also explore how liquid biopsies can be incorporated in cancer patient management and how implementation of liquid biopsies can change clinical practice. Topics to be Covered: From basic discoveries to clinical application using minimally invasive clinical bio-specimens. Circulating nucleic acids (ctDNA and RNA), circulating tumor cells, exosomes, patient-derived models (CDX) and CTC cultures. Additional details will be posted as soon as they are available.

10th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) is organized by Services Comunicazione Eventi Cultura (CEC) srl / Servizi Comunicazione Eventi Cultura (CEC) s.r.l. and will be held from Apr 17 - 19, 2020 at Bergamo, Lombardia, Italy. Course Description: The aim of ICTHIC is to review the recent advances in the understanding of the pathogenesis, prevention and treatment of thrombotic and hemorrhagic complications in cancer patients, both from the basic and clinical research points of view. Course Topics: • Epidemiology • Thromboprophylaxis in Medical Patients • Treatment of VTE • Thromboprophylaxis in Surgical Patients • Hypercoagulation and Biomarkers • Complement-driven Thrombotic Syndromes • Gender- and Age-related Issues • Hemostasis in Cancer Biology • Molecular Mechanisms of Thrombosis in Cancer • Tumor Cell/Vascular Cell Interactions • Angiogenesis • Inflammation • New Antithrombotic Drugs • Anticoagulation and Cancer Survival • Arterial Thrombosis • Bleeding • Congenital and Acquired Risk Factors • Thrombohemorrhagic Syndromes • Thrombocytopenia in cancer • Antitumor Properties of Antithrombotics • Microparticles • New Assays for Hypercoagulability • Fibrinolysis • Proteases Additional details will be posted as soon as they are available.